aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (81172015, 81572417)
  • Huazhong University of Science and Technology (540- 5001540068)

This publication has 49 references indexed in Scilit: